How Statins Affect Cell Death in Lung Cells
Author Information
Author(s): Ghavami Saeid, Mutawe Mark M., Sharma Pawan, Yeganeh Behzad, McNeill Karol D., Klonisch Thomas, Unruh Helmut, Kashani Hessam H., Schaafsma Dedmer, Los Marek, Halayko Andrew J.
Primary Institution: University of Manitoba
Hypothesis
Does the inhibition of the mevalonate cascade by statins induce autophagy and apoptosis in human airway mesenchymal cells?
Conclusion
Statins induce both autophagy and apoptosis in human airway mesenchymal cells, with autophagy acting as a protective mechanism against apoptosis.
Supporting Evidence
- Simvastatin increased autophagosome formation in airway mesenchymal cells.
- Autophagy markers appeared before apoptosis markers in response to simvastatin treatment.
- Blocking autophagy with inhibitors increased apoptosis in simvastatin-treated cells.
- p53 was shown to regulate both autophagy and apoptosis in this context.
Takeaway
Statins can help lung cells survive stress by making them eat up their damaged parts, but they can also cause the cells to die if the stress is too much.
Methodology
The study used primary cultured human airway smooth muscle and fibroblast cells to assess the effects of simvastatin on autophagy and apoptosis through various biochemical assays.
Potential Biases
Potential bias due to the use of specific cell lines and the focus on a single type of treatment (simvastatin).
Limitations
The study primarily focused on in vitro models, which may not fully replicate in vivo conditions.
Participant Demographics
Human airway mesenchymal cells and fibroblasts derived from resected lung specimens.
Statistical Information
P-Value
p<0.001
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website